Skip to content
NYSEDHR
Danaher Announces Appointment of Elias A. Zerhouni, M.D. as Director
PRNewswire-FirstCall
WASHINGTON

Danaher Corporation announced today that its Board of Directors has appointed Elias A. Zerhouni, M.D. to Danaher's Board of Directors. Dr. Zerhouni's initial term expires at Danaher's 2011 annual meeting of shareholders.

Dr. Zerhouni, a physician, scientist, and world-renowned leader in radiology research, served as director of the National Institutes of Health from 2002 to 2008 and currently serves as Senior Advisor at Johns Hopkins University School of Medicine and as Senior Fellow for the Bill and Melinda Gates Foundation Global Health Program. Dr. Zerhouni earned his medical degree in 1975 from the University of Algiers. After completing his residency in diagnostic radiology at Johns Hopkins in 1978 as chief resident, he rose to the rank of full professor of radiology in 1992 and biomedical engineering in 1995. In 1996, he was named director of the Department of Radiology. During the following years, he rose rapidly within Hopkins, assuming additional duties as vice dean for clinical affairs and president of the Johns Hopkins Clinical Practice Association, vice dean for research and executive vice dean for the Johns Hopkins University School of Medicine.

Under his leadership, the NIH embarked on a number of initiatives, chief among them the Roadmap for Medical Research, designed to enhance synergy and collaborative work among all 27 NIH institutes and centers and leading to the passing by the US Congress of the NIH Reform Act of 2006. Other new programs included those designed to foster high-risk but potentially high-impact research, and enhanced support for young career scientists.

Steven M. Rales, Chairman of the Board of Danaher Corporation, said, "We are delighted Dr. Zerhouni is joining our board. We expect he will be an insightful and valuable contributor, especially given our growing presence in medical technologies."

Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our brands are typically among the most recognized in the markets we serve. With the Danaher Business System as our foundation, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. For more information please visit our website: www.danaher.com.

Statements in this release that are not strictly historical may be "forward-looking" statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements, including the factors described in our SEC filings, including our 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended October 2, 2009. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation to update any forward-looking statement.

First Call Analyst:
FCMN Contact:

SOURCE: Danaher Corporation

CONTACT: Matt R. McGrew, Vice President, Investor Relations, Danaher
Corporation, +1-202-828-0850, or Fax, +1-202-828-0860